• The event is an Analyst/Institutional Investor group meeting.
  • The meeting is scheduled for Friday, September 25, 2026, from 11:00 AM to 12:00 Noon.
  • The stated purpose is for officials of the company to interact with analysts and institutional investors.
  • The meeting will be conducted in a virtual format.
  • The intimation letter does not specify the management participants or their designations.
  • An Investor Presentation has been uploaded on the Stock Exchanges and on the Company's website (www.supriyalifescience.com) for public information.
  • The document does not indicate if the meeting is scheduled before or after an earnings announcement.
  • The document contains no statement regarding the sharing of unpublished price sensitive information (UPSI).
  • No financial highlights, guidance references, or presentation summaries are included in this specific disclosure.

Additional Notes Section

  • The document is a compliance submission pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • A note clarifies that the scheduled date is subject to change due to exigencies on the part of the Company or the Analyst/Investor/Fund.
  • No financial data was disclosed in this announcement.